SCHEMBL735693

SCHEMBL735693

COc1cccc(P)c1OC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.50
CA12 O43570 2/20 0.48
CA1 P00915 2/20 0.48
CA2 P00918 2/20 0.48
CA7 P43166 2/20 0.48
CA9 Q16790 2/20 0.48
CA14 Q9ULX7 2/20 0.48
CA4 P22748 1/20 0.48
NFE2L2 Q16236 5/20 0.44
MAPK1 P28482 2/20 0.43
KDM4E B2RXH2 2/20 0.43
MAPT P10636 2/20 0.43
HSD17B10 Q99714 2/20 0.43
ALDH1A1 P00352 1/20 0.43
LMNA P02545 1/20 0.43
TP53 P04637 1/20 0.43
CYP3A4 P08684 1/20 0.43
HPGD P15428 1/20 0.43
ALOX15 P16050 1/20 0.43
ALOX12 P18054 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL28639461 0.98 SMN1; SMN2 (0.48) SMN1; SMN2CA12CA1CA2CA7
SCHEMBL20591149 0.88 SMN1; SMN2 (0.46) SMN1; SMN2CA12CA1CA2CA7
SCHEMBL27753904 0.82 CA1 (0.61) SMN1; SMN2CA12CA1CA2CA7
SCHEMBL25434306 0.82 CA1 (0.61) SMN1; SMN2CA12CA1CA2CA7
SCHEMBL151213 0.82 CA1 (0.61) SMN1; SMN2CA12CA1CA2CA7
SCHEMBL28554675 0.81 APP (0.46) SMN1; SMN2CA12CA1CA2CA7
SCHEMBL29174503 0.81 APP (0.50) SMN1; SMN2CA12CA1CA2CA7
SCHEMBL13144640 0.80 CA1 (0.52) SMN1; SMN2CA12CA1CA2CA7
SCHEMBL9879828 0.80 MGAM (0.44) SMN1; SMN2CA12CA1CA2CA7
Ammonia Solution, Strong SCHEMBL4268652 0.79 SMN1; SMN2 (0.58) SMN1; SMN2CA12CA1CA2CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 187 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119930491-A Synthesis method of polysubstituted pyrrolidone 北京化工大学 2025-05-06 CN claimed
CN-118420667-A Triazinyl compound with flame retardant and light stability performance and preparation method thereof 宿迁联盛科技股份有限公司 2024-08-02 CN claimed
CN-112920047-A Process for preparing 4-acetoxy-2-methyl-2-butene-1-aldehyde and intermediates thereof 江西天新药业股份有限公司 2021-06-08 CN claimed
CN-111518145-A Cyanide-bridged metal organic compound with intramolecular magnetic transformation, and preparation method and application thereof 荆楚理工学院 2020-08-11 CN claimed
CN-106518805-A New method for simple synthesis of 2, 4-disubstituted selenazole compound 中国科学院生态环境研究中心 2017-03-22 CN claimed
US-7834130-B2 Process for the production of polybenzimidazole from a tetraminobiphenyl and an isophthalic acid PBI PERFORMANCE PRODUCTS, INC. (US) 2010-11-16 US claimed
US-20080207869-A1 PROCESS FOR THE PRODUCTION OF POLYBENZIMIDAZOLE FROM A TETRAMINOBIPHENYL AND AN ISOPHTHALIC ACID PBI PERFORMANCE PRODUCTS, INC. 2008-08-28 US claimed
CN-100402152-C Trimerisation of olefins using a catalyst comprising a source of chromium, molybdenum or tungsten and a ligand comprising at least one phosphorus, arsenic or antimony atom bound to at least one (hetero) hydrocarbyl group BP CHEM INT LTD (GB) 2008-07-16 CN claimed
CN-1823116-A Coating compositions containing aminofunctional silicone resins DOW CORNING (US) 2006-08-23 CN claimed
CN-1630554-A Trimerisation of olefins using a catalyst containing chromium, molybdenum or tungsten and a ligand containing phosphorus, arsenic or antimony BP CHEM INT LTD (GB) 2005-06-22 CN claimed
EP-0095348-B1 HIGH MOLECULAR WEIGHT POLYBENZIMIDAZOLES CELANESE CORPORATION (US) 1986-04-09 EP claimed
EP-0095348-A2 High molecular weight polybenzimidazoles CELANESE CORPORATION (US) 1983-11-30 EP claimed
US-4414383-A High molecular weight polybenzimidazole preparation with phosphorus containing polymerization catalyst CELANESE CORPORATION (US) 1983-11-08 US claimed
US-20260079286-A1 Structured Film and Optical Article Including Structured Film 3M INNOVATIVE PROPERTIES COMPANY (US) 2026-03-19 US disclosed
US-12517285-B2 Multilayer optical films comprising at least one fluorinated (co)polymer layer made using a fluorinated photoinitiator, and methods of making and using the same 3M INNOVATIVE PROPERTIES COMPANY (US) 2026-01-06 US disclosed
US-12504567-B2 Structured film and optical article including structured film 3M INNOVATIVE PROPERTIES COMPANY (US) 2025-12-23 US disclosed
US-4324744-A PHOTOINITIATORS BASF AKTIENGESELLSCHAFT (DE) 1982-04-13 US disclosed
US-4298738-A PHOTOINITIATORS IN PHOTOPOLYMERIZABLE COATINGS AND IMKS BASF AKTIENGESELLSCHAFT (DE) 1981-11-03 US disclosed
US-4265723-A UNSATURATED POLYESTERS OR VINYL ESTERS OF POLYEPOXIDES AND A UV SENSITIZER OF AN ACYL PHOSPHINE OXIDE BASF AKTIENGESELLSCHAFT (DE) 1981-05-05 US disclosed
US-3992456-A BY REACTING BUTADIENE WITH WATER IN THE PRESENCE OF A PALLADIUM CATALYST UNION CARBIDE CORPORATION (US) 1976-11-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260079286-A1 Structured Film and Optical Article Including Structured Film CDH1, ICAM1, SAAL1 SMN1; SMN2 2372/4885CA12 2222/4885CA1 2142/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.